News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Martina Sluga-O’Callaghan

Articles by Martina Sluga-O’Callaghan

9 Real-world Treatment Patterns and Clinical Outcomes in Patients Treated With Eribulin After Prior Immunotherapy (IO) or Antibody-Drug Conjugate (ADC) for Metastatic Breast Cancer

ByRavi K. Goyal,Jingchuan Zhang,Samina Dhuliawala,Martina Sluga-O’Callaghan,Peter A. Kaufman, MD

April 18th 2022

Latest Updated Articles

9 Real-world Treatment Patterns and Clinical Outcomes in Patients Treated With Eribulin After Prior Immunotherapy (IO) or Antibody-Drug Conjugate (ADC) for Metastatic Breast Cancer
Published: April 18th 2022 | Updated:

Trending on CancerNetwork

More Global Expertise and Talent Are Needed to Administer Cell Therapies

FDA Grants Priority Review to Enfortumab Vedotin Combo in MIBC Subset

Raludotatug Deruxtecan Shows Promise in Platinum-Resistant Ovarian Cancer

Examining the Full Scope of Future Advancements in Radiation Oncology

Oral SERD Regimen May Prolong Efficacy in Second-Line Breast Cancer Care

© 2025 MJH Life Sciences^®

All rights reserved.